Type your tag names separated by a space and hit enter

    Ionized magnesium levels and the ratio of ionized calcium to magnesium in asthma patients before and after treatment with magnesium.

    Abstract

    OBJECTIVE

    Prior studies have been equivocal about the efficacy of magnesium therapy in acute asthma exacerbations. We hypothesize that pretreatment ionized magnesium (Mg(2+)) levels and/or the ratio of ionized calcium to ionized magnesium (Ca(2+)/Mg(2+)) may have been confounding variables in these previous studies. Here, we report on the incidence of abnormal divalent ion levels in our asthma population.

    MATERIAL AND METHODS

    The study was designed as a randomized, double-blind, placebo-controlled trial of intravenous magnesium. Inclusion criteria were: age >18 years, percentage predicted forced expiratory volume (FEV(1)) <75 % after an initial beta-agonist. African-American patients (AA) at an urban university hospital were randomized to 2 g IV Mg or placebo. Mg(2+) and Ca(2+)/Mg(2+) levels were measured pre- and post-infusion. Data were reported as means+/-SD. Student's t-test and Fisher's exact test were used where appropriate (alpha = 0.05, two tailed).

    RESULTS

    Fifty-five AA patients (mean age of 42.7 years+/-15.6 years, range 18-75 years) were studied. A significantly (p<0.05) lower level of Mg(2+) was found in asthma (AS) patients compared with that in the AA group, by 0.03 mmol/L (95 % CI, 0.007-0.053 mmol/L). The AS group had a mean increase in Ca(2+)/Mg(2+) ratios over the AA group, of 0.27 (95 % CI, 0.16-0.38); 100 % of patients with abnormal divalent ion levels were corrected with IV magnesium.

    CONCLUSIONS

    We identified a subgroup of asthmatic patients with significant abnormalities in their divalent ion concentrations, which was corrected with IV magnesium.

    Links

  • Publisher Full Text

    • Grapherence [↓4]

    Authors+Show Affiliations

    Sinert R
    ,

    Department of Emergency Medicine, State University of New York, Downstate Medical Center, Brooklyn, NY 11203, USA. nephron1@bellatlantic.net

    Spektor M
    ,
    Gorlin A
    ,
    Doty C
    ,
    Rubin A
    ,
    Altura BT
    ,
    Altura BM

    Source

    MeSH

    Adolescent
    Adult
    Aged
    Asthma
    Calcium
    Female
    Humans
    Ions
    Magnesium
    Male
    Middle Aged

    Pub Type(s)

    Journal Article
    Randomized Controlled Trial

    Language

    eng

    PubMed ID

    16319040

    Citation

    Sinert, R, et al. "Ionized Magnesium Levels and the Ratio of Ionized Calcium to Magnesium in Asthma Patients Before and After Treatment With Magnesium." Scandinavian Journal of Clinical and Laboratory Investigation, vol. 65, no. 8, 2005, pp. 659-70.
    Sinert R, Spektor M, Gorlin A, et al. Ionized magnesium levels and the ratio of ionized calcium to magnesium in asthma patients before and after treatment with magnesium. Scand J Clin Lab Invest. 2005;65(8):659-70.
    Sinert, R., Spektor, M., Gorlin, A., Doty, C., Rubin, A., Altura, B. T., & Altura, B. M. (2005). Ionized magnesium levels and the ratio of ionized calcium to magnesium in asthma patients before and after treatment with magnesium. Scandinavian Journal of Clinical and Laboratory Investigation, 65(8), pp. 659-70.
    Sinert R, et al. Ionized Magnesium Levels and the Ratio of Ionized Calcium to Magnesium in Asthma Patients Before and After Treatment With Magnesium. Scand J Clin Lab Invest. 2005;65(8):659-70. PubMed PMID: 16319040.
    * Article titles in AMA citation format should be in sentence-case
    TY - JOUR T1 - Ionized magnesium levels and the ratio of ionized calcium to magnesium in asthma patients before and after treatment with magnesium. AU - Sinert,R, AU - Spektor,M, AU - Gorlin,A, AU - Doty,C, AU - Rubin,A, AU - Altura,B T, AU - Altura,B M, PY - 2005/12/2/pubmed PY - 2006/3/8/medline PY - 2005/12/2/entrez SP - 659 EP - 70 JF - Scandinavian journal of clinical and laboratory investigation JO - Scand. J. Clin. Lab. Invest. VL - 65 IS - 8 N2 - OBJECTIVE: Prior studies have been equivocal about the efficacy of magnesium therapy in acute asthma exacerbations. We hypothesize that pretreatment ionized magnesium (Mg(2+)) levels and/or the ratio of ionized calcium to ionized magnesium (Ca(2+)/Mg(2+)) may have been confounding variables in these previous studies. Here, we report on the incidence of abnormal divalent ion levels in our asthma population. MATERIAL AND METHODS: The study was designed as a randomized, double-blind, placebo-controlled trial of intravenous magnesium. Inclusion criteria were: age >18 years, percentage predicted forced expiratory volume (FEV(1)) <75 % after an initial beta-agonist. African-American patients (AA) at an urban university hospital were randomized to 2 g IV Mg or placebo. Mg(2+) and Ca(2+)/Mg(2+) levels were measured pre- and post-infusion. Data were reported as means+/-SD. Student's t-test and Fisher's exact test were used where appropriate (alpha = 0.05, two tailed). RESULTS: Fifty-five AA patients (mean age of 42.7 years+/-15.6 years, range 18-75 years) were studied. A significantly (p<0.05) lower level of Mg(2+) was found in asthma (AS) patients compared with that in the AA group, by 0.03 mmol/L (95 % CI, 0.007-0.053 mmol/L). The AS group had a mean increase in Ca(2+)/Mg(2+) ratios over the AA group, of 0.27 (95 % CI, 0.16-0.38); 100 % of patients with abnormal divalent ion levels were corrected with IV magnesium. CONCLUSIONS: We identified a subgroup of asthmatic patients with significant abnormalities in their divalent ion concentrations, which was corrected with IV magnesium. SN - 0036-5513 UR - https://www.unboundmedicine.com/medline/citation/16319040/Ionized_magnesium_levels_and_the_ratio_of_ionized_calcium_to_magnesium_in_asthma_patients_before_and_after_treatment_with_magnesium_ L2 - http://www.tandfonline.com/doi/full/10.1080/00365510500333825 DB - PRIME DP - Unbound Medicine ER -